ออมเดียคาด อัตราการใช้กำลังโรงงานผลิตจอแสดงผลชนิดบางเรียบ (FPD) พร้อมฟื้นตัวและเติบโตตั้งแต่ครึ่งหลังของปี 2567

ลอนดอน, 24 พ.ค. 2567 /PRNewswire/ — ตลอดประวัติศาสตร์ของอุตสาหกรรมจอแสดงผลชนิดบางเรียบ (flat panel display หรือ FPD) อัตราการใช้กำลังโรงงานผลิตโดยเฉลี่ยมักจะอยู่ที่ราว 84% อย่างไรก็ตาม ระหว่างไตรมาสที่ 3 ของปี 2565 ถึงไตรมาสที่ 4 ของปี 2566 ขณะที่ตลาดจอ FPD ประสบความยากลำบากที่จะฟื้นตัวหลังจากภาวะอุปทานล้นเกินในช่วงวิกฤตโรคระบาด อัตราการใช้กำลังผลิตในทั้งอุตสาหกรรมลดลงอย่างมากเป็น 70.7% Utilization forecast เมื่อถึงจุดที่อุปสงค์เติบโตรวดเร็วกว่าการขยายตัวของกำลังผลิต จะเอื้อให้อัตราการใช้กำลังโรงงานผลิตที่มุ่งเน้นจอขนาดใหญ่สามารถเพิ่มสูงขึ้นเป็นเกือบ 90% ในไตรมาสที่ 3 ของปี 2567 และอยู่ในระดับดีในปีต่อ ๆ ไปในอนาคต จากข้อมูลที่เพิ่งเผยแพร่ในรายงานติดตามอุปทาน อุปสงค์ และอุปกรณ์ OLED และ LCD (OLED and LCD Supply Demand and Equipment Tracker) ของ ออมเดีย […]

Busting fear barrier about hormone replacement therapy in new era of menopause management

MANILA, Philippines, May 24, 2024 /PRNewswire/ — Millions of women around the world continue to suffer unnecessarily from the physical and psychological effects of the menopause because of “mistaken fears” about the risks and benefits of hormone replacement therapy. A world leader in human fertility and women’s health has warned that continued under-utilisation of menopausal […]

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

SUZHOU, China and ROCKVILLE, Md., May 24, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its four abstracts selected for presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting are now available on ASCO’s official website. […]

Jia Xudong, partner of Fintopia, emphasized the importance of three dimensions for financial technology to go global

BEIJING, May 24, 2024 /PRNewswire/ — A news report from ifeng.com: Recently, the Alibaba Cloud International Summit, with the core theme of “Orange Cloud Going Global, New Journey of Financial Technology”, was grandly held. Jia Xudong, partner of Fintopia, was invited to attend the conference, where he joined many industry experts to discuss the future […]

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 24, 2024 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based […]

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 24, 2024 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based […]

CNOOC Limited Subsidiaries Signed EPCCs with MIREME and ENH

HONG KONG, May 24, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces its wholly owned subsidiaries have entered into petroleum exploration and production concession contracts (EPCCs) with the Ministry of Mineral Resources and Energy of Mozambique (MIREME) and Empresa Nacional de Hidrocarbonetos (ENH) for 5 […]

Antengene To Present One Oral and Four Abstracts at ASCO 2024

Oral Presentation:a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer Three Poster presentations: Phase I/II studies of ATG-031 (anti-CD24 monoclonal antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and selinexor (XPO1 Inhibitor) Journal Publication: the first-in-human Phase I dose-escalation study of ATG-017 (ERK1/2 inhibitor) in patients with advanced solid […]

ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE

Operation aims to strengthen the Company’s financial position and maintain growth strategy SAO PAULO, May 24, 2024 /PRNewswire/ — Oncoclínicas&Co (B3: ONCO3), a leading oncology company headquartered in Latin America, has announced that the enterprise has approved a capital increase of R$ 1.5 billion at a Board of Directors meeting held on May 22, 2024. […]

ZERO LATENCY ANNOUNCES THE RELEASE DATE FOR WARHAMMER 40,000: SPACE MARINE VR – DEFENDERS OF AVARAX, COMING OCTOBER 2024

Set in the Warhammer 40,000: Space Marine universe, the exclusive new free-roam VR experience will be available at Zero Latency’s 90+ venues globally. MELBOURNE, Australia, May 24, 2024 /PRNewswire/ — Zero Latency , the global leader in immersive entertainment and creator of the largest true in-person free-roam VR network in the world, has revealed the release […]

SEMIFIVE Signs MOU with Atron Technologies to Collaborate on Semiconductor Design

Expected to expand global business in the Chinese market SEOUL, South Korea, May 24, 2024 /PRNewswire/ — SEMIFIVE, a leading design solution provider and pioneer of platform-based custom silicon solutions, has announced its agreement of MOU with China-based Atron Technologies, on May 23, 2024. Through this agreement, SEMIFIVE and Atron Technologies will collaborate on comprehensive […]

Emeren Announces First Quarter 2024 Financial Results

STAMFORD, Conn., May 24, 2024 /PRNewswire/ — Emeren Group Ltd (“Emeren” or the “Company”) (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced its unaudited financial results for the first quarter ended March 31, 2024. Emeren’s first quarter 2024 financial results and management commentary can be found by accessing the Company’s […]

1 1,829 1,830 1,831 3,145